By remanufacturing single-use medical devices, Vanguard significantly reduces CO₂ emissions, material consumption, and waste volumes. These climate and resource benefits strengthen both the Carbon Handprint and the wider Environmental Handprint, ensuring that the...
The Reason for the Lawsuit Innovative Health accused BSW of employing tactics that discourage hospitals from using reprocessed catheters supplied by Innovative Health. Biosense Webster was alleged to have leveraged its market dominance to pressure hospitals into...
Legal Framework Establishes the Foundation Decree No. 2025-895 defines the legal framework for the national pilot phase and aligns it with the European Medical Device Regulation (MDR) (EU) 2017/745 and the Implementing Regulation (EU) 2020/1207. Reprocessing...
AMDR publishes procurement policy to protect reprocessing programmes The Association of Medical Device Reprocessors (AMDR) has introduced a new template for hospitals and healthcare systems:the „Reprocessing and Fair Contracting Policy Template“. This document is...
We are restructuring our Operations Team to strengthen collaboration between our sites in Aschersleben, Berlin and Friedeburg, and to further enhance the efficiency of our processes. The Operations Team brings together the Executive Board, Technical Services and...
Since 1 January 2025, it has been officially permitted in Denmark to have highly specialised single-use medical devices reprocessed. To make it easier for hospitals to adopt this practice, financial support has been introduced: DKK 0.5 million in 2025, DKK 1.5 million...
